Jeff Marrazzo, Spark CEO
With Spark safely tucked into Roche, its founding CEO is off to search for new adventures
Spark Therapeutics made history at the FDA by winning the first-ever approval for a gene therapy, when the agency greenlighted Luxturna in late 2017 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.